7-107563979-A-C
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_181581.3(DUS4L):c.-341A>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.00030 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
DUS4L
NM_181581.3 5_prime_UTR
NM_181581.3 5_prime_UTR
Scores
19
Clinical Significance
Conservation
PhyloP100: 0.232
Genes affected
DUS4L (HGNC:21517): (dihydrouridine synthase 4 like) Predicted to enable tRNA dihydrouridine synthase activity. Predicted to be involved in tRNA dihydrouridine synthesis. [provided by Alliance of Genome Resources, Apr 2022]
COG5 (HGNC:14857): (component of oligomeric golgi complex 5) The protein encoded by this gene is one of eight proteins (Cog1-8) which form a Golgi-localized complex (COG) required for normal Golgi morphology and function. The encoded protein is organized with conserved oligomeric Golgi complex components 6, 7 and 8 into a sub-complex referred to as lobe B. Alternative splicing results in multiple transcript variants. Mutations in this gene result in congenital disorder of glycosylation type 2I.[provided by RefSeq, Jan 2011]
DUS4L-BCAP29 (HGNC:54422): (DUS4L-BCAP29 readthrough) This locus represents naturally occurring readthrough transcription between the neighboring DUS4L (dihydrouridine synthase 4 like) and BCAP29 (B cell receptor associated protein 29) genes on chromosome 7. The readthrough transcript encodes a fusion protein that shares sequence identity with each individual gene product. [provided by RefSeq, Jul 2019]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.045625895).
BP6
Variant 7-107563979-A-C is Benign according to our data. Variant chr7-107563979-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 1206117.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr7-107563979-A-C is described in Lovd as [Likely_benign].
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DUS4L | ENST00000265720 | c.-341A>C | 5_prime_UTR_variant | Exon 1 of 8 | 2 | NM_181581.3 | ENSP00000265720.3 | |||
DUS4L-BCAP29 | ENST00000673757 | c.-341A>C | 5_prime_UTR_variant | Exon 1 of 15 | ENSP00000501026.1 | |||||
COG5 | ENST00000297135.9 | c.-83T>G | upstream_gene_variant | 1 | NM_006348.5 | ENSP00000297135.4 |
Frequencies
GnomAD3 genomes AF: 0.000306 AC: 43AN: 140454Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
43
AN:
140454
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00 AC: 0AN: 174986 AF XY: 0.00
GnomAD2 exomes
AF:
AC:
0
AN:
174986
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00114 AC: 521AN: 457192Hom.: 0 Cov.: 24 AF XY: 0.000981 AC XY: 242AN XY: 246802 show subpopulations
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
521
AN:
457192
Hom.:
Cov.:
24
AF XY:
AC XY:
242
AN XY:
246802
Gnomad4 AFR exome
AF:
AC:
9
AN:
13438
Gnomad4 AMR exome
AF:
AC:
2
AN:
31516
Gnomad4 ASJ exome
AF:
AC:
5
AN:
12412
Gnomad4 EAS exome
AF:
AC:
6
AN:
13762
Gnomad4 SAS exome
AF:
AC:
14
AN:
64198
Gnomad4 FIN exome
AF:
AC:
2
AN:
28868
Gnomad4 NFE exome
AF:
AC:
464
AN:
271676
Gnomad4 Remaining exome
AF:
AC:
18
AN:
19732
⚠️ The allele balance in gnomAD4 Exomes is highly skewed (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Heterozygous variant carriers
0
104
209
313
418
522
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.000299 AC: 42AN: 140546Hom.: 0 Cov.: 32 AF XY: 0.000337 AC XY: 23AN XY: 68224 show subpopulations
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
42
AN:
140546
Hom.:
Cov.:
32
AF XY:
AC XY:
23
AN XY:
68224
Gnomad4 AFR
AF:
AC:
0.000153539
AN:
0.000153539
Gnomad4 AMR
AF:
AC:
0.00020871
AN:
0.00020871
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0.000238892
AN:
0.000238892
Gnomad4 SAS
AF:
AC:
0.00100705
AN:
0.00100705
Gnomad4 FIN
AF:
AC:
0.00153447
AN:
0.00153447
Gnomad4 NFE
AF:
AC:
0.000234031
AN:
0.000234031
Gnomad4 OTH
AF:
AC:
0
AN:
0
⚠️ The allele balance in gnomAD4 Genomes is highly skewed (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Heterozygous variant carriers
0
8
16
24
32
40
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
not provided Benign:2
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Benign
DEOGEN2
Benign
T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N;N
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
B;B;.
Vest4
MutPred
Gain of relative solvent accessibility (P = 0.0166);Gain of relative solvent accessibility (P = 0.0166);Gain of relative solvent accessibility (P = 0.0166);
MVP
MPC
0.067
ClinPred
T
GERP RS
Varity_R
gMVP
Mutation Taster
=99/1
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at